Year To Quarter End Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7714364

Concept 2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
14,247,000,000 JPY
16,859,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-542,000,000 JPY
1,288,000,000 JPY
Remeasurements of defined benefit plans, net of tax
197,000,000 JPY
333,000,000 JPY
Other comprehensive income
-345,000,000 JPY
1,621,000,000 JPY
Comprehensive income
13,901,000,000 JPY
18,481,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
13,901,000,000 JPY
18,481,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.